Navigation Links
China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC
Date:9/7/2010

China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC -- BOSTON, Sept. 7 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Pharmaceuticals Click to view news release full screen  

China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC

 

BOSTON, Sept. 7 /PRNewswire/ -- China PharmaHub Corp. (OTC Bulletin Board: CPHB) ("PharmaHub"), which recently merged with World Wide Relics (OTC Bulletin Board: WRLC) and, effective August 23, 2010, changed its name from World Wide Relics, Inc. to China PharmaHub Corp., announced today that effective Tuesday, September 7, 2010, its stock shall begin trading under the symbol "CPHB."  The change has been announced in FINRA's Daily List for September 3, 2010 to be effective September 7, 2010.  

(Logo: http://photos.prnewswire.com/prnh/20100907/LA60053LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100907/LA60053LOGO)

The purpose of the name change is to better reflect PharmaHub's goals of becoming a global pharmaceutical HUB that specializes in the identification, licensing, development and commercialization of pharmaceutical and healthcare products and technologies that its management believes could make a significant difference to patients and society worldwide. PharmaHub's corporate goal is to create maximum value from existing intellectual properties and technologies of its global partners by utilizing its broad-base of knowledge, understanding and resource allocation ability in the pharmaceutical and healthcare industries.

Richard Lui, CEO of PharmaHub stated, "We are thrilled to being trading under a symbol which better reflects our corporate goals and also reflects the name under which we were originally founded.  Since founding, we have been forming relationships with and have built what we believe is a strong foundation of strategic alliances, partnerships and joint ventures.  We believe that our new trading symbol reflects the progress we have made in becoming a solid bridge between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the U.S. and Europe.  

About PharmaHub:China PharmaHub Corp. is engaged in the business of licensing, developing and the commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the United States and Europe. Management believes that PharmaHub brings a unique wealth of resources to assist scientists and companies in bringing their ideas to reality.  PharmaHub's corporate headquarters are located in California, with offices in Boston and China. For more information visit www.chnpharmahub.com.

Forward-Looking StatementsThis press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein. Contact:Contact:Monica DingChief Financial OfficerTel:  (909)843-6388 Cell: (626) 589-5136Email: ir@chnpharmahub.com
'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical Updates Financial Guidance for 2010
2. China-Biotics Announces September 20 Investor Day Schedule
3. China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results
4. Wise Sky Highlights Their Disappointment at Emergents Decision Not to Enter the China Market
5. Reportlinker Adds The Market for Medical Devices in Brazil, Russia, India & China
6. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
7. China-Biotics to Host Investor Day in Shanghai to Discuss Corporate Development Strategy
8. BMP Sunstones Hao Wawa (Good Baby) Brand Ranked First Among Chinas Top Three Pediatric Medicine Brands
9. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
10. China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
11. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... , June 30, 2017 In vitro ... the start of May, at least ten diagnostic companies ... private investments, public offerings and a loan facility.  The ... to almost $80 million.  Kalorama Information provides a monthly ... its Diagnostics Knowledge Center. ...
(Date:6/30/2017)... HIGH POINT, N.C. , June 29, 2017  Axium Pharmaceuticals ... innovations for developing improved novel formulations and alternative dosage forms ... ... transmucosal delivery is based on our waterless self-nano emulsifying formula, ... after contact with saliva. We believe the spray will provide ...
(Date:6/27/2017)... , Jun 27, 2017   NuEyes (NuEyes Technologies ... funding to fuel its growth in helping the legally blind ... (Osterhout Design Group), the leading developer of augmented, virtual and ... sits. The undisclosed funding amount was provided by ... Arab Angel, with offices in Abu Dhabi ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... (ACL) offer patients improved quality of life five years after injury, according to ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five years ...
(Date:7/20/2017)... Viejo, CA (PRWEB) , ... July 20, 2017 , ... ... when placed between two clips in the FCPX timeline. This effect isolates horizontal and ... transition in this package contains either a rotating or flipping animation and can be ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):